Xermelo approved for tumor-related diarrhea
(HealthDay)—Xermelo (telotristat ethyl) tablets have been approved by the U.S. Food and Drug Administration to treat adults with carcinoid syndrome diarrhea, one of a collection of symptoms related to rare carcinoid tumors.
Mar 1, 2017
0
0